Head-To-Head Analysis: West Bancorporation (WTBA) & Its Competitors

Head-To-Head Analysis: West Bancorporation (WTBA) & Its Competitors

West Bancorporation (NASDAQ: WTBA) is one of 261 public companies in the “State commercial banks” industry, but how does it compare to its rivals? We will compare West Bancorporation to related businesses based on the strength of its risk, dividends, analyst recommendations, profitability, institutional ownership, valuation and earnings. Analyst Ratings This is a summary of current recommendations for West Bancorporation and its rivals, as provided by MarketBeat.com. West Bancorporation currently has a consensus target price of $27.00, suggesting a potential upside of 23.01%. As a group, “State commercial banks” companies…

FORTESCUE METAL/S (FSUGY) and Its Peers Head-To-Head Analysis

FORTESCUE METAL/S (FSUGY) and Its Peers Head-To-Head Analysis

FORTESCUE METAL/S (OTCMKTS: FSUGY) is one of 51 public companies in the “Metal mining” industry, but how does it contrast to its competitors? We will compare FORTESCUE METAL/S to related companies based on the strength of its analyst recommendations, dividends, profitability, valuation, institutional ownership, risk and earnings. Valuation and Earnings This table compares FORTESCUE METAL/S and its competitors revenue, earnings per share (EPS) and valuation. FORTESCUE METAL/S has higher revenue and earnings than its competitors. FORTESCUE METAL/S is trading at a lower price-to-earnings ratio than its competitors, indicating that it…

Head-To-Head Analysis: Inventergy Global (INVT) & Zayo Group (ZAYO)

Head-To-Head Analysis: Inventergy Global (INVT) & Zayo Group (ZAYO)

Zayo Group (NYSE:ZAYO) and Inventergy Global (OTCMKTS:INVT) are both computer and technology companies, but which is the better investment? We will compare the two companies based on the strength of their risk, dividends, analyst recommendations, institutional ownership, valuation, earnings and profitability. Profitability This table compares Zayo Group and Inventergy Global’s net margins, return on equity and return on assets. Risk and Volatility Zayo Group has a beta of 0.43, indicating that its share price is 57% less volatile than the S&P 500. Comparatively, Inventergy Global has a beta of -0.45,…

M&T Bank Co. (MTB) Forecasted to Post FY2018 Earnings of $13.09 Per Share

M&T Bank Co. (MTB) Forecasted to Post FY2018 Earnings of $13.09 Per Share

M&T Bank Co. (NYSE:MTB) – Analysts at Wedbush issued their FY2018 EPS estimates for M&T Bank in a report released on Thursday, October 18th. Wedbush analyst P. Winter expects that the financial services provider will post earnings of $13.09 per share for the year. Wedbush has a “Hold” rating and a $188.00 price objective on the stock. M&T Bank (NYSE:MTB) last posted its earnings results on Wednesday, October 17th. The financial services provider reported $3.53 EPS for the quarter, topping the consensus estimate of $3.35 by $0.18. M&T Bank had…

Goldcorp (GG) Set to Announce Quarterly Earnings on Wednesday

Goldcorp (GG) Set to Announce Quarterly Earnings on Wednesday

Goldcorp (NYSE:GG) (TSE:G) will be issuing its quarterly earnings data after the market closes on Wednesday, October 24th. Analysts expect the company to announce earnings of $0.05 per share for the quarter. Goldcorp (NYSE:GG) (TSE:G) last released its quarterly earnings data on Wednesday, July 25th. The basic materials company reported $0.05 EPS for the quarter, missing analysts’ consensus estimates of $0.07 by ($0.02). The company had revenue of $793.00 million for the quarter, compared to analysts’ expectations of $871.54 million. Goldcorp had a return on equity of 1.97% and a…

William Blair Comments on RLI Corp.’s FY2018 Earnings (RLI)

William Blair Comments on RLI Corp.’s FY2018 Earnings (RLI)

RLI Corp. (NYSE:RLI) – Equities research analysts at William Blair decreased their FY2018 earnings per share (EPS) estimates for RLI in a note issued to investors on Thursday, October 18th. William Blair analyst A. Klauber now anticipates that the insurance provider will post earnings of $2.16 per share for the year, down from their previous forecast of $2.25. William Blair also issued estimates for RLI’s FY2020 earnings at $2.15 EPS. RLI (NYSE:RLI) last posted its quarterly earnings data on Wednesday, October 17th. The insurance provider reported $0.46 earnings per share…

Allegheny Technologies (ATI) Set to Announce Earnings on Tuesday

Allegheny Technologies (ATI) Set to Announce Earnings on Tuesday

Allegheny Technologies (NYSE:ATI) will issue its quarterly earnings data before the market opens on Tuesday, October 23rd. Analysts expect the company to announce earnings of $0.38 per share for the quarter. Allegheny Technologies (NYSE:ATI) last released its quarterly earnings data on Tuesday, July 24th. The basic materials company reported $0.52 EPS for the quarter, beating the consensus estimate of $0.36 by $0.16. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $1 billion. Allegheny Technologies had a return on equity of 7.84% and…

Research Analysts Set Expectations for Gulfport Energy Co.’s FY2018 Earnings (GPOR)

Research Analysts Set Expectations for Gulfport Energy Co.’s FY2018 Earnings (GPOR)

Gulfport Energy Co. (NASDAQ:GPOR) – Research analysts at Imperial Capital increased their FY2018 earnings estimates for Gulfport Energy in a research report issued to clients and investors on Friday, October 19th. Imperial Capital analyst J. Wangler now anticipates that the oil and gas producer will post earnings of $1.56 per share for the year, up from their prior estimate of $1.50. Gulfport Energy (NASDAQ:GPOR) last issued its quarterly earnings results on Wednesday, August 1st. The oil and gas producer reported $0.33 earnings per share (EPS) for the quarter, topping analysts’…

Analysts Expect Enova International Inc (ENVA) Will Announce Quarterly Sales of $267.54 Million

Analysts Expect Enova International Inc (ENVA) Will Announce Quarterly Sales of $267.54 Million

Wall Street brokerages expect Enova International Inc (NYSE:ENVA) to post $267.54 million in sales for the current fiscal quarter, Zacks reports. Two analysts have made estimates for Enova International’s earnings, with the highest sales estimate coming in at $269.00 million and the lowest estimate coming in at $266.07 million. Enova International reported sales of $217.88 million in the same quarter last year, which indicates a positive year-over-year growth rate of 22.8%. The company is scheduled to report its next earnings report after the market closes on Thursday, October 25th. According…

ZEALAND PHARMA/S (ZEAL) vs. RegeneRx Biopharmaceuticals (RGRX) Financial Survey

ZEALAND PHARMA/S (ZEAL) vs. RegeneRx Biopharmaceuticals (RGRX) Financial Survey

ZEALAND PHARMA/S (NASDAQ:ZEAL) and RegeneRx Biopharmaceuticals (OTCMKTS:RGRX) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, risk, institutional ownership, valuation, analyst recommendations, dividends and profitability. Analyst Recommendations This is a summary of current ratings for ZEALAND PHARMA/S and RegeneRx Biopharmaceuticals, as provided by MarketBeat.com. ZEALAND PHARMA/S currently has a consensus target price of $29.00, suggesting a potential upside of 123.08%. RegeneRx Biopharmaceuticals has a consensus target price of $1.50, suggesting a potential upside of 733.33%….

Contrasting Arlo Technologies (ARLO) and Knowles (KN)

Contrasting Arlo Technologies (ARLO) and Knowles (KN)

Arlo Technologies (NYSE:ARLO) and Knowles (NYSE:KN) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, valuation, institutional ownership, analyst recommendations, earnings, risk and dividends. Profitability This table compares Arlo Technologies and Knowles’ net margins, return on equity and return on assets. Valuation & Earnings This table compares Arlo Technologies and Knowles’ revenue, earnings per share (EPS) and valuation. Knowles has higher revenue and earnings than Arlo Technologies. Analyst Recommendations This is a breakdown…

Comparing General Motors (GM) & VOLKSWAGEN (VLKAY)

Comparing General Motors (GM) & VOLKSWAGEN (VLKAY)

General Motors (NYSE:GM) and VOLKSWAGEN (OTCMKTS:VLKAY) are both auto/tires/trucks companies, but which is the better stock? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, profitability, earnings, valuation, risk and dividends. Valuation and Earnings This table compares General Motors and VOLKSWAGEN’s top-line revenue, earnings per share (EPS) and valuation. VOLKSWAGEN has higher revenue and earnings than General Motors. General Motors is trading at a lower price-to-earnings ratio than VOLKSWAGEN, indicating that it is currently the more affordable of the two stocks. Profitability This…

Nuveen Municipal High Income Oppty Fund (NMZ) Plans $0.06 Monthly Dividend

Nuveen Municipal High Income Oppty Fund (NMZ) Plans $0.06 Monthly Dividend

Nuveen Municipal High Income Oppty Fund (NYSE:NMZ) declared a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Investors of record on Monday, October 15th will be given a dividend of 0.0565 per share on Thursday, November 1st. This represents a $0.68 annualized dividend and a yield of 5.76%. The ex-dividend date of this dividend is Friday, October 12th. Nuveen Municipal High Income Oppty Fund has decreased its dividend payment by an average of 4.3% per year over the last three years. NMZ stock opened at $11.77 on Monday….

Nuveen Energy MLP Total Return Fund (JMF) Plans $0.25 Quarterly Dividend

Nuveen Energy MLP Total Return Fund (JMF) Plans $0.25 Quarterly Dividend

Nuveen Energy MLP Total Return Fund (NYSE:JMF) announced a quarterly dividend on Tuesday, October 2nd, Wall Street Journal reports. Investors of record on Monday, October 15th will be given a dividend of 0.25 per share on Thursday, November 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 9.55%. The ex-dividend date of this dividend is Friday, October 12th. Nuveen Energy MLP Total Return Fund has increased its dividend by an average of 1.7% per year over the last three years. JMF opened at $10.47…

Nuveen Select Tax-Free Incom Portfolio 3 (NXR) Plans $0.04 Monthly Dividend

Nuveen Select Tax-Free Incom Portfolio 3 (NXR) Plans $0.04 Monthly Dividend

Nuveen Select Tax-Free Incom Portfolio 3 (NYSE:NXR) declared a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Shareholders of record on Monday, October 15th will be given a dividend of 0.0435 per share by the investment management company on Thursday, November 1st. This represents a $0.52 dividend on an annualized basis and a yield of 3.67%. The ex-dividend date of this dividend is Friday, October 12th. Nuveen Select Tax-Free Incom Portfolio 3 has decreased its dividend payment by an average of 5.6% per year over the last three…

Nuveen High Income Dec 2018 Trgt Trm Fnd (JHA) to Issue Monthly Dividend of $0.03

Nuveen High Income Dec 2018 Trgt Trm Fnd (JHA) to Issue Monthly Dividend of $0.03

Nuveen High Income Dec 2018 Trgt Trm Fnd (NYSE:JHA) declared a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Stockholders of record on Monday, October 15th will be paid a dividend of 0.027 per share on Thursday, November 1st. This represents a $0.32 annualized dividend and a dividend yield of 3.29%. The ex-dividend date is Friday, October 12th. Shares of JHA opened at $9.85 on Monday. Nuveen High Income Dec 2018 Trgt Trm Fnd has a 52 week low of $9.67 and a 52 week high of $10.02….

Nuveen Preferred & Income Oprtnts Fnd (JPC) Plans Monthly Dividend of $0.06

Nuveen Preferred & Income Oprtnts Fnd (JPC) Plans Monthly Dividend of $0.06

Nuveen Preferred & Income Oprtnts Fnd (NYSE:JPC) announced a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Shareholders of record on Monday, October 15th will be paid a dividend of 0.061 per share by the financial services provider on Thursday, November 1st. This represents a $0.73 dividend on an annualized basis and a dividend yield of 8.31%. The ex-dividend date is Friday, October 12th. Nuveen Preferred & Income Oprtnts Fnd has raised its dividend payment by an average of 0.7% per year over the last three years. Shares…

Tile Shop (NASDAQ:TTS) PT Lowered to $7.00

Tile Shop (NASDAQ:TTS) PT Lowered to $7.00

Tile Shop (NASDAQ:TTS) had its price objective lowered by equities researchers at Loop Capital to $7.00 in a research note issued to investors on Friday, October 5th, The Fly reports. The brokerage presently has a “positive” rating on the stock. Loop Capital’s target price would suggest a potential upside of 13.45% from the company’s previous close. Several other research analysts have also recently issued reports on TTS. BidaskClub cut shares of Tile Shop from a “buy” rating to a “hold” rating in a report on Saturday, June 30th. ValuEngine cut…

Nuveen New York Dividend Advntg Mncpl Fd Declares Monthly Dividend of $0.05 (NAN)

Nuveen New York Dividend Advntg Mncpl Fd Declares Monthly Dividend of $0.05 (NAN)

Nuveen New York Dividend Advntg Mncpl Fd (NYSE:NAN) announced a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Investors of record on Monday, October 15th will be given a dividend of 0.048 per share by the financial services provider on Thursday, November 1st. This represents a $0.58 dividend on an annualized basis and a yield of 4.74%. The ex-dividend date of this dividend is Friday, October 12th. Nuveen New York Dividend Advntg Mncpl Fd has decreased its dividend payment by an average of 2.4% annually over the last…

Nuveen New Jersey Dividend Advantg Mncpl (NXJ) to Issue $0.05 Monthly Dividend

Nuveen New Jersey Dividend Advantg Mncpl (NXJ) to Issue $0.05 Monthly Dividend

Nuveen New Jersey Dividend Advantg Mncpl (NYSE:NXJ) announced a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Stockholders of record on Monday, October 15th will be paid a dividend of 0.0545 per share on Thursday, November 1st. This represents a $0.65 annualized dividend and a dividend yield of 5.21%. The ex-dividend date of this dividend is Friday, October 12th. Nuveen New Jersey Dividend Advantg Mncpl has raised its dividend by an average of 1.0% per year over the last three years. Shares of NXJ opened at $12.55 on…

Mylan (MYL) Downgraded by Mizuho to “Neutral”

Mylan (MYL) Downgraded by Mizuho to “Neutral”

Mylan (NASDAQ:MYL) was downgraded by analysts at Mizuho from a “buy” rating to a “neutral” rating in a report issued on Friday, October 5th, Marketbeat reports. Several other research analysts have also commented on the company. ValuEngine lowered Mylan from a “hold” rating to a “sell” rating in a research report on Tuesday, September 11th. Cowen reiterated a “hold” rating and issued a $31.00 target price on shares of Mylan in a research report on Thursday, August 9th. Wells Fargo & Co restated a “hold” rating on shares of Mylan…

Cyclacel Pharmaceuticals (CYCC) Given a $8.00 Price Target by Roth Capital Analysts

Cyclacel Pharmaceuticals (CYCC) Given a $8.00 Price Target by Roth Capital Analysts

Cyclacel Pharmaceuticals (NASDAQ:CYCC) received a $8.00 target price from analysts at Roth Capital in a research note issued to investors on Thursday, October 4th. The firm currently has a “buy” rating on the biotechnology company’s stock. Roth Capital’s price target indicates a potential upside of 467.38% from the stock’s previous close. Several other equities analysts have also recently weighed in on CYCC. Zacks Investment Research upgraded Cyclacel Pharmaceuticals from a “sell” rating to a “hold” rating in a report on Wednesday, June 6th. HC Wainwright set a $7.00 price objective…

Nuveen Va Premium Income Municipal Fund (NPV) Plans $0.04 Monthly Dividend

Nuveen Va Premium Income Municipal Fund (NPV) Plans $0.04 Monthly Dividend

Nuveen Va Premium Income Municipal Fund (NYSE:NPV) announced a monthly dividend on Tuesday, October 2nd, Wall Street Journal reports. Stockholders of record on Monday, October 15th will be given a dividend of 0.0435 per share by the financial services provider on Thursday, November 1st. This represents a $0.52 annualized dividend and a dividend yield of 4.54%. The ex-dividend date is Friday, October 12th. Nuveen Va Premium Income Municipal Fund has decreased its dividend payment by an average of 9.5% annually over the last three years. Nuveen Va Premium Income Municipal…

Brainstorm Cell Therapeutics (BCLI) and Krystal Biotech (KRYS) Head-To-Head Analysis

Brainstorm Cell Therapeutics (BCLI) and Krystal Biotech (KRYS) Head-To-Head Analysis

Brainstorm Cell Therapeutics (NASDAQ:BCLI) and Krystal Biotech (NASDAQ:KRYS) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, dividends and analyst recommendations. Analyst Recommendations This is a summary of current recommendations for Brainstorm Cell Therapeutics and Krystal Biotech, as provided by MarketBeat.com. Brainstorm Cell Therapeutics presently has a consensus price target of $10.00, indicating a potential upside of 191.55%. Krystal Biotech has a consensus price target of $35.88, indicating a potential…

Natera (NASDAQ:NTRA) Now Covered by JPMorgan Chase & Co.

Natera (NASDAQ:NTRA) Now Covered by JPMorgan Chase & Co.

JPMorgan Chase & Co. started coverage on shares of Natera (NASDAQ:NTRA) in a report published on Friday, October 5th, MarketBeat.com reports. The firm issued a neutral rating and a $26.00 price objective on the medical research company’s stock. Other equities analysts have also issued reports about the stock. Craig Hallum upped their price target on shares of Natera from $23.00 to $30.00 and gave the stock a buy rating in a research report on Thursday, August 9th. Zacks Investment Research upgraded shares of Natera from a hold rating to a…

Critical Survey: Jounce Therapeutics (NASDAQ:JNCE) and Coherus Biosciences (CHRS)

Critical Survey: Jounce Therapeutics (NASDAQ:JNCE) and Coherus Biosciences (CHRS)

Coherus Biosciences (NASDAQ:CHRS) and Jounce Therapeutics (NASDAQ:JNCE) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Risk and Volatility Coherus Biosciences has a beta of 3.66, meaning that its stock price is 266% more volatile than the S&P 500. Comparatively, Jounce Therapeutics has a beta of 5.33, meaning that its stock price is 433% more volatile than the S&P 500. Earnings and Valuation This table compares…

Zacks: Analysts Expect ConocoPhillips (COP) Will Post Earnings of $1.15 Per Share

Zacks: Analysts Expect ConocoPhillips (COP) Will Post Earnings of $1.15 Per Share

Wall Street brokerages forecast that ConocoPhillips (NYSE:COP) will post $1.15 earnings per share (EPS) for the current fiscal quarter, Zacks Investment Research reports. Three analysts have made estimates for ConocoPhillips’ earnings. The lowest EPS estimate is $0.99 and the highest is $1.30. ConocoPhillips reported earnings per share of $0.16 in the same quarter last year, which indicates a positive year-over-year growth rate of 618.8%. The business is scheduled to announce its next quarterly earnings report before the market opens on Thursday, October 25th. On average, analysts expect that ConocoPhillips will…

HC Wainwright Analysts Give Amyris (AMRS) a $15.00 Price Target

HC Wainwright Analysts Give Amyris (AMRS) a $15.00 Price Target

HC Wainwright set a $15.00 target price on Amyris (NASDAQ:AMRS) in a research report released on Thursday, October 4th. The brokerage currently has a buy rating on the biotechnology company’s stock. Several other research firms also recently weighed in on AMRS. Zacks Investment Research downgraded Amyris from a hold rating to a sell rating in a research report on Thursday, August 9th. BidaskClub upgraded Amyris from a hold rating to a buy rating in a research report on Wednesday, August 15th. B. Riley set a $10.00 price target on Amyris…

Financial Comparison: Netlist (NLST) and Qorvo (QRVO)

Financial Comparison: Netlist (NLST) and Qorvo (QRVO)

Netlist (NASDAQ:NLST) and Qorvo (NASDAQ:QRVO) are both computer and technology companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Institutional and Insider Ownership 7.1% of Netlist shares are held by institutional investors. Comparatively, 94.1% of Qorvo shares are held by institutional investors. 12.9% of Netlist shares are held by insiders. Comparatively, 0.9% of Qorvo shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and…

Financial Comparison: Teekay Offshore Partners (TOO) and Carnival (CCL)

Financial Comparison: Teekay Offshore Partners (TOO) and Carnival (CCL)

Teekay Offshore Partners (NYSE:TOO) and Carnival (NYSE:CCL) are both transportation companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Insider & Institutional Ownership 75.9% of Teekay Offshore Partners shares are held by institutional investors. Comparatively, 76.4% of Carnival shares are held by institutional investors. 23.8% of Carnival shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock…

Critical Survey: Misonix (NASDAQ:MSON) and Cesca Therapeutics (KOOL)

Critical Survey: Misonix (NASDAQ:MSON) and Cesca Therapeutics (KOOL)

Cesca Therapeutics (NASDAQ:KOOL) and Misonix (NASDAQ:MSON) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Risk and Volatility Cesca Therapeutics has a beta of -0.97, meaning that its stock price is 197% less volatile than the S&P 500. Comparatively, Misonix has a beta of 0.29, meaning that its stock price is 71% less volatile than the S&P 500. Valuation & Earnings This table compares Cesca Therapeutics…

iShares Core S&P 500 ETF (IVV) Stake Lessened by Russell Investments Group Ltd.

iShares Core S&P 500 ETF (IVV) Stake Lessened by Russell Investments Group Ltd.

Russell Investments Group Ltd. lowered its stake in shares of iShares Core S&P 500 ETF (NYSEARCA:IVV) by 10.0% during the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 1,800 shares of the company’s stock after selling 200 shares during the quarter. Russell Investments Group Ltd.’s holdings in iShares Core S&P 500 ETF were worth $491,000 as of its most recent SEC filing. Several other institutional investors and hedge funds also recently bought and sold shares…

Analysts Expect Lindsay Co. (LNN) Will Announce Earnings of $0.85 Per Share

Analysts Expect Lindsay Co. (LNN) Will Announce Earnings of $0.85 Per Share

Analysts forecast that Lindsay Co. (NYSE:LNN) will announce earnings of $0.85 per share for the current quarter, according to Zacks Investment Research. Two analysts have issued estimates for Lindsay’s earnings, with estimates ranging from $0.63 to $1.08. Lindsay reported earnings per share of $0.59 in the same quarter last year, which suggests a positive year-over-year growth rate of 44.1%. The business is scheduled to announce its next quarterly earnings results on Thursday, October 11th. On average, analysts expect that Lindsay will report full year earnings of $3.25 per share for…

Cerus (CERS) Rating Lowered to Hold at Zacks Investment Research

Cerus (CERS) Rating Lowered to Hold at Zacks Investment Research

Zacks Investment Research lowered shares of Cerus (NASDAQ:CERS) from a buy rating to a hold rating in a research report report published on Friday, October 5th. According to Zacks, “Cerus Corporation is developing medical products based on a platform technology that prevents nucleic acid replication. The company’s initial application of this technology is the development of systems to inactivate viruses, bacteria and other pathogens in blood components used for transfusion. The company is also focusing research and development efforts on other potential health care applications for this platform technology, including…

Head-To-Head Comparison: NTT Docomo (DCMYY) and Its Competitors

Head-To-Head Comparison: NTT Docomo (DCMYY) and Its Competitors

NTT Docomo (OTCMKTS: DCMYY) is one of 43 publicly-traded companies in the “Radio & t.v. communications equipment” industry, but how does it compare to its peers? We will compare NTT Docomo to similar businesses based on the strength of its risk, dividends, valuation, earnings, analyst recommendations, profitability and institutional ownership. Profitability This table compares NTT Docomo and its peers’ net margins, return on equity and return on assets. Analyst Ratings This is a breakdown of current ratings and price targets for NTT Docomo and its peers, as reported by MarketBeat.com….

Critical Survey: Inpixon (NASDAQ:INPX) and Computer Programs & Systems (CPSI)

Critical Survey: Inpixon (NASDAQ:INPX) and Computer Programs & Systems (CPSI)

Computer Programs & Systems (NASDAQ:CPSI) and Inpixon (NASDAQ:INPX) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Risk & Volatility Computer Programs & Systems has a beta of -0.13, suggesting that its share price is 113% less volatile than the S&P 500. Comparatively, Inpixon has a beta of 2.79, suggesting that its share price is 179% more volatile than the S&P 500. Earnings and Valuation This…

Critical Survey: Lonestar Resources US (LONE) and Canadian Natural Resource (CNQ)

Critical Survey: Lonestar Resources US (LONE) and Canadian Natural Resource (CNQ)

Canadian Natural Resource (NYSE:CNQ) and Lonestar Resources US (NASDAQ:LONE) are both oils/energy companies, but which is the superior investment? We will contrast the two businesses based on the strength of their institutional ownership, dividends, analyst recommendations, risk, profitability, valuation and earnings. Risk & Volatility Canadian Natural Resource has a beta of 1.23, suggesting that its share price is 23% more volatile than the S&P 500. Comparatively, Lonestar Resources US has a beta of 0.38, suggesting that its share price is 62% less volatile than the S&P 500. Earnings and Valuation…

Schwab Charles Investment Management Inc. Has $3.56 Million Stake in Intellia Therapeutics Inc (NASDAQ:NTLA)

Schwab Charles Investment Management Inc. Has $3.56 Million Stake in Intellia Therapeutics Inc (NASDAQ:NTLA)

Schwab Charles Investment Management Inc. boosted its position in shares of Intellia Therapeutics Inc (NASDAQ:NTLA) by 42.4% during the 2nd quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 130,108 shares of the company’s stock after buying an additional 38,723 shares during the quarter. Schwab Charles Investment Management Inc. owned approximately 0.30% of Intellia Therapeutics worth $3,560,000 as of its most recent SEC filing. A number of other large investors have also recently bought and sold shares of the business. Wells Fargo…

Russell Investments Group Ltd. Invests $448,000 in Cardtronics PLC (CATM)

Russell Investments Group Ltd. Invests $448,000 in Cardtronics PLC (CATM)

Russell Investments Group Ltd. acquired a new position in Cardtronics PLC (NASDAQ:CATM) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 18,461 shares of the business services provider’s stock, valued at approximately $448,000. A number of other large investors have also added to or reduced their stakes in the stock. Hudson Executive Capital LP lifted its position in shares of Cardtronics by 228.3% during the first quarter. Hudson Executive Capital LP now owns 6,387,830 shares of the business services…

Russell Investments Group Ltd. Grows Stake in LSC Communications Inc (LKSD)

Russell Investments Group Ltd. Grows Stake in LSC Communications Inc (LKSD)

Russell Investments Group Ltd. increased its holdings in shares of LSC Communications Inc (NYSE:LKSD) by 174.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 27,093 shares of the company’s stock after acquiring an additional 17,213 shares during the period. Russell Investments Group Ltd. owned approximately 0.08% of LSC Communications worth $423,000 as of its most recent SEC filing. A number of other hedge funds have also made changes to their positions in LKSD. Piedmont Investment Advisors LLC acquired…

Banco Santander Mexico Sa Instcn De (BSMX) versus Canadian Imperial Bank of Commerce (NYSE:CM) Financial Analysis

Banco Santander Mexico Sa Instcn De (BSMX) versus Canadian Imperial Bank of Commerce (NYSE:CM) Financial Analysis

Canadian Imperial Bank of Commerce (NYSE:CM) and Banco Santander Mexico Sa Instcn De (NYSE:BSMX) are both finance companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, earnings, analyst recommendations, dividends, valuation, profitability and institutional ownership. Analyst Recommendations This is a breakdown of current recommendations for Canadian Imperial Bank of Commerce and Banco Santander Mexico Sa Instcn De, as reported by MarketBeat. Canadian Imperial Bank of Commerce presently has a consensus price target of $121.14, indicating a potential upside of…

MarketAxess Holdings Inc. to Post Q4 2018 Earnings of $1.05 Per Share, William Blair Forecasts (NASDAQ:MKTX)

MarketAxess Holdings Inc. to Post Q4 2018 Earnings of $1.05 Per Share, William Blair Forecasts (NASDAQ:MKTX)

MarketAxess Holdings Inc. (NASDAQ:MKTX) – Equities researchers at William Blair raised their Q4 2018 earnings per share estimates for MarketAxess in a report issued on Tuesday, October 2nd, according to Zacks Investment Research. William Blair analyst C. Shutler now anticipates that the financial services provider will post earnings of $1.05 per share for the quarter, up from their prior estimate of $1.03. William Blair also issued estimates for MarketAxess’ Q1 2019 earnings at $1.41 EPS and Q4 2019 earnings at $1.27 EPS. MarketAxess (NASDAQ:MKTX) last issued its quarterly earnings results…

Russell Investments Group Ltd. Grows Holdings in Rite Aid Co. (RAD)

Russell Investments Group Ltd. Grows Holdings in Rite Aid Co. (RAD)

Russell Investments Group Ltd. raised its position in Rite Aid Co. (NYSE:RAD) by 119.5% during the second quarter, according to its most recent filing with the SEC. The institutional investor owned 245,756 shares of the company’s stock after purchasing an additional 133,800 shares during the period. Russell Investments Group Ltd.’s holdings in Rite Aid were worth $429,000 at the end of the most recent quarter. A number of other hedge funds have also recently made changes to their positions in RAD. Destination Wealth Management lifted its holdings in Rite Aid…

Eagle Pharmaceuticals Inc (EGRX) Shares Bought by Legal & General Group Plc

Eagle Pharmaceuticals Inc (EGRX) Shares Bought by Legal & General Group Plc

Legal & General Group Plc lifted its stake in Eagle Pharmaceuticals Inc (NASDAQ:EGRX) by 8.5% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 17,758 shares of the specialty pharmaceutical company’s stock after purchasing an additional 1,385 shares during the period. Legal & General Group Plc owned about 0.12% of Eagle Pharmaceuticals worth $1,346,000 at the end of the most recent quarter. Other hedge funds and other institutional investors also recently bought and sold shares…

HomeStreet Inc (NASDAQ:HMST) Shares Bought by Schwab Charles Investment Management Inc.

HomeStreet Inc (NASDAQ:HMST) Shares Bought by Schwab Charles Investment Management Inc.

Schwab Charles Investment Management Inc. raised its position in shares of HomeStreet Inc (NASDAQ:HMST) by 6.4% during the second quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 138,411 shares of the financial services provider’s stock after acquiring an additional 8,282 shares during the period. Schwab Charles Investment Management Inc. owned approximately 0.51% of HomeStreet worth $3,731,000 as of its most recent filing with the Securities & Exchange Commission. A number of other hedge funds have also recently bought and sold…

Jaffetilchin Investment Partners LLC Buys New Holdings in WEC Energy Group Inc (NYSE:WEC)

Jaffetilchin Investment Partners LLC Buys New Holdings in WEC Energy Group Inc (NYSE:WEC)

Jaffetilchin Investment Partners LLC acquired a new stake in shares of WEC Energy Group Inc (NYSE:WEC) during the 3rd quarter, according to the company in its most recent 13F filing with the SEC. The firm acquired 4,681 shares of the utilities provider’s stock, valued at approximately $313,000. Several other institutional investors also recently bought and sold shares of the company. Natixis Advisors L.P. raised its position in WEC Energy Group by 30.5% in the 1st quarter. Natixis Advisors L.P. now owns 27,292 shares of the utilities provider’s stock worth $1,711,000…

Jaffetilchin Investment Partners LLC Buys Shares of 3,979 Henry Schein, Inc. (NASDAQ:HSIC)

Jaffetilchin Investment Partners LLC Buys Shares of 3,979 Henry Schein, Inc. (NASDAQ:HSIC)

Jaffetilchin Investment Partners LLC acquired a new position in Henry Schein, Inc. (NASDAQ:HSIC) during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 3,979 shares of the company’s stock, valued at approximately $338,000. Other institutional investors have also modified their holdings of the company. Gabelli Funds LLC boosted its position in Henry Schein by 3.5% during the second quarter. Gabelli Funds LLC now owns 343,900 shares of the company’s stock valued at $24,981,000 after acquiring an…

27,441 Shares in Cabot Microelectronics Co. (CCMP) Acquired by Raymond James & Associates

27,441 Shares in Cabot Microelectronics Co. (CCMP) Acquired by Raymond James & Associates

Raymond James & Associates purchased a new stake in shares of Cabot Microelectronics Co. (NASDAQ:CCMP) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund purchased 27,441 shares of the semiconductor company’s stock, valued at approximately $2,952,000. Raymond James & Associates owned 0.11% of Cabot Microelectronics as of its most recent filing with the Securities & Exchange Commission. A number of other large investors also recently added to or reduced their stakes in CCMP. Aperio Group LLC…

Brokerages Set Bombardier, Inc. Class B (BBD.B) Price Target at $5.77

Brokerages Set Bombardier, Inc. Class B (BBD.B) Price Target at $5.77

Shares of Bombardier, Inc. Class B (TSE:BBD.B) have been assigned an average rating of “Buy” from the eighteen ratings firms that are presently covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a hold rating and twelve have given a buy rating to the company. The average 1 year price target among analysts that have issued a report on the stock in the last year is C$5.77. BBD.B has been the subject of a number of research analyst reports. Royal Bank of Canada raised their target…

Capitol Federal Financial (NASDAQ:CFFN) Downgraded by BidaskClub

Capitol Federal Financial (NASDAQ:CFFN) Downgraded by BidaskClub

Capitol Federal Financial (NASDAQ:CFFN) was downgraded by stock analysts at BidaskClub from a “sell” rating to a “strong sell” rating in a report issued on Thursday, October 4th. Shares of CFFN stock opened at $12.33 on Thursday. The company has a current ratio of 1.37, a quick ratio of 1.37 and a debt-to-equity ratio of 1.70. Capitol Federal Financial has a 1 year low of $12.03 and a 1 year high of $15.11. The company has a market cap of $1.74 billion, a price-to-earnings ratio of 18.97 and a beta…